Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: An open, randomized, controlled trial

Takahiko Kurasawa, Hayato Nagasawa, Mayumi Kishimoto, Koichi Amano, Tsutomu Takeuchi, Hideto Kameda

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: An open, randomized, controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences